← Leaderboards
John D Haley
Osi Pharmaceuticals, Inc.
$2,215,661
Attributed
$3,226,616
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $651.6K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,226,616 · 5
By mechanism
R01$2,021,911 · 2
P01$961,366 · 2
R44$243,339 · 1
Top collaborators
- Allen Bruce Futcher3 shared
- Louis Daniel Scampavia3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsEnzymesMalignant NeoplasmsBasePharmaceutical PreparationsProteinsSuccessRegulationSphingolipidsResearch PersonnelMass Spectrum AnalysisMetabolicProceduresFutureHigh Pressure Liquid ChromatographyBiologyCeramidesLipidsAnalogProteomicsIn VitroIn VivoTechnologyTranscriptome Sequencing
Grant awards (12)
Core B: Lipodomics Core$193,044
P01 · FY2023 · CA · contact PI
Mechanistic characterization of quantitative trait genetics affecting cell metabolism$100,000
R01 · FY2023 · GM
Mechanistic characterization of quantitative trait genetics affecting cell metabolism$331,931
R01 · FY2022 · GM
Core B: Lipodomics Core$189,184
P01 · FY2022 · CA · contact PI
Mechanistic characterization of quantitative trait genetics affecting cell metabolism$331,931
R01 · FY2021 · GM
Core B: Lipodomics Core$193,046
P01 · FY2021 · CA · contact PI
Development of neutral ceramidase inhibitor tool compounds$390,301
R01 · FY2020 · CA · contact PI
Core B: Lipodomics Core$193,046
P01 · FY2020 · CA · contact PI
Development of neutral ceramidase inhibitor tool compounds$458,558
R01 · FY2019 · CA · contact PI
Core B: Lipodomics Core$193,046
P01 · FY2019 · CA · contact PI
Development of neutral ceramidase inhibitor tool compounds$409,190
R01 · FY2018 · CA · contact PI
AMELIORATION OF ORAL MUCOSITIS IN ANIMAL MODELS$243,339
R44 · FY2000 · DE